College of Biological Science and Engineering, Fuzhou University, Fuzhou, 350108, Fujian, China.
College of Chemistry, Fuzhou University, Fuzhou, 350108, Fujian, China.
J Nat Prod. 2022 May 27;85(5):1332-1339. doi: 10.1021/acs.jnatprod.2c00080. Epub 2022 Apr 26.
Protein disulfide isomerase (PDI) is a vital oxidoreductase. Extracellular PDI promotes thrombus formation but does not affect physiological blood hemostasis. Inhibition of extracellular PDI has been demonstrated as a promising strategy for antithrombotic treatment. Herein, we focused on the major substrate binding site, a unique pocket in the PDI b' domain, and identified four natural products binding to PDI by combining virtual screening with tryptophan fluorescence-based assays against a customized natural product library. These hits all directly bound to the PDI-b' domain and inhibited the reductase activity of PDI. Among them, galangin showed the most prominent potency (5.9 μM) against PDI and as a broad-spectrum inhibitor for vascular thiol isomerases. studies manifested that galangin delayed the time of blood vessel occlusion in an electricity-induced mouse thrombosis model. Molecular docking and dynamics simulation further revealed that the hydroxyl-substituted benzopyrone moiety of galangin deeply inserted into the interface between the PDI-b' substrate-binding pocket and the a' domain. Together, these findings provide a potential antithrombotic drug candidate and demonstrate that the PDI b' domain is a critical domain for inhibitor development. Besides, we also report an innovative high-throughput screening method for the rapid discovery of PDI b' targeted inhibitors.
蛋白二硫键异构酶(PDI)是一种重要的氧化还原酶。细胞外 PDI 促进血栓形成,但不影响生理止血。抑制细胞外 PDI 已被证明是一种有前途的抗血栓治疗策略。在这里,我们专注于主要的底物结合位点,即 PDI b' 结构域中的一个独特口袋,并通过将虚拟筛选与色氨酸荧光测定法相结合,针对定制的天然产物文库,鉴定出四种与 PDI 结合的天然产物。这些命中物都直接结合到 PDI-b' 结构域,并抑制 PDI 的还原酶活性。其中,白杨素对 PDI 的抑制作用最为显著(5.9 μM),是一种广谱的血管硫醇异构酶抑制剂。研究表明,白杨素可延迟电诱导的小鼠血栓模型中血管闭塞的时间。分子对接和动力学模拟进一步表明,白杨素的羟基取代苯并吡喃部分深入插入 PDI-b' 底物结合口袋和 a' 结构域之间的界面。总之,这些发现为潜在的抗血栓药物候选物提供了依据,并证明了 PDI b' 结构域是抑制剂开发的关键结构域。此外,我们还报告了一种创新的高通量筛选方法,用于快速发现 PDI b' 靶向抑制剂。